Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 19
1982 14
1983 33
1984 77
1985 198
1986 130
1987 134
1988 121
1989 155
1990 129
1991 114
1992 88
1993 61
1994 60
1995 57
1996 81
1997 64
1998 72
1999 56
2000 66
2001 66
2002 55
2003 68
2004 65
2005 83
2006 69
2007 70
2008 78
2009 68
2010 79
2011 86
2012 96
2013 102
2014 116
2015 138
2016 115
2017 117
2018 130
2019 127
2020 179
2021 200
2022 199
2023 227
2024 113

Text availability

Article attribute

Article type

Publication date

Search Results

4,130 results

Results by year

Filters applied: . Clear all
Page 1
Aztreonam.
Cunha BA. Cunha BA. Urology. 1993 Mar;41(3):249-58. doi: 10.1016/0090-4295(93)90568-u. Urology. 1993. PMID: 8442309 Review.
Aztreonam is the first monobactam and is unique among beta-lactam antibiotics for its spectrum of activity that is exclusively active against gram-negative aerobic bacteria. Broad clinical experience with this agent supports its use in the treatment of adults with severe o …
Aztreonam is the first monobactam and is unique among beta-lactam antibiotics for its spectrum of activity that is exclusively active …
Aztreonam.
Tunkel AR, Scheld WM. Tunkel AR, et al. Infect Control Hosp Epidemiol. 1990 Sep;11(9):486-94. doi: 10.1086/646216. Infect Control Hosp Epidemiol. 1990. PMID: 2230052 Review.
Aztreonam, the first commercially available monobactam, has a wide range of activity against aerobic gram-negative bacilli. ...Aztreonam is a useful addition to the available antibiotics for treatment of gram-negative infections....
Aztreonam, the first commercially available monobactam, has a wide range of activity against aerobic gram-negative bacilli. ...Azt …
Aztreonam.
Clark P. Clark P. Obstet Gynecol Clin North Am. 1992 Sep;19(3):519-28. Obstet Gynecol Clin North Am. 1992. PMID: 1436929 Review.
Aztreonam is a synthetic monobactam antibiotic that has excellent activity against aerobic gram-negative bacilli. ...
Aztreonam is a synthetic monobactam antibiotic that has excellent activity against aerobic gram-negative bacilli. ...
Aztreonam.
Johnson DH, Cunha BA. Johnson DH, et al. Med Clin North Am. 1995 Jul;79(4):733-43. doi: 10.1016/s0025-7125(16)30036-0. Med Clin North Am. 1995. PMID: 7791420 Free article. Review.
Aztreonam is a monocyclic beta-lactam antibiotic that is active exclusively against the aerobic gram-negative bacilli. ...Overuse of aztreonam should be avoided to prevent the emergence of resistant P. aeruginosa strains. ...
Aztreonam is a monocyclic beta-lactam antibiotic that is active exclusively against the aerobic gram-negative bacilli. ...Overuse of …
Aztreonam.
Childs SJ, Bodey GP. Childs SJ, et al. Pharmacotherapy. 1986 Jul-Aug;6(4):138-52. doi: 10.1002/j.1875-9114.1986.tb03468.x. Pharmacotherapy. 1986. PMID: 3534798 Review.
Aztreonam is a new, totally synthetic beta-lactamase agent--the first monobactam. ...Particularly in light of its safety and unique properties, aztreonam promises to be a useful alternative to aminoglycoside therapy....
Aztreonam is a new, totally synthetic beta-lactamase agent--the first monobactam. ...Particularly in light of its safety and unique p …
Multicenter Evaluation of an MIC-Based Aztreonam and Ceftazidime-Avibactam Broth Disk Elution Test.
Harris H, Tao L, Jacobs EB, Bergman Y, Adebayo A, Tekle T, Lewis S, Dahlquist A, Abbey TC, Wenzler E, Humphries R, Simner PJ. Harris H, et al. J Clin Microbiol. 2023 May 23;61(5):e0164722. doi: 10.1128/jcm.01647-22. Epub 2023 Apr 18. J Clin Microbiol. 2023. PMID: 37070979 Free PMC article.
Due to limited therapeutic options, there is a clinical need to assess the in vitro activity of the combination of aztreonam (ATM) and ceftazidime-avibactam (CZA) to guide the therapeutic management of multidrug-resistant (MDR) Gram-negative organism infections. ...
Due to limited therapeutic options, there is a clinical need to assess the in vitro activity of the combination of aztreonam (ATM) an …
Aztreonam: clinical pharmacology.
Stutman HR. Stutman HR. Pediatr Infect Dis J. 1989 Sep;8(9 Suppl):S104-8; discussion S128-32. Pediatr Infect Dis J. 1989. PMID: 2682507 Review.
Monocyclic beta-lactam antibiotics (monobactams) are structurally unique from the traditional bicyclic beta-lactams because of their single ring configuration. Aztreonam, the first of these monobactams, has been studied extensively in order to determine its pharmacologic a …
Monocyclic beta-lactam antibiotics (monobactams) are structurally unique from the traditional bicyclic beta-lactams because of their single …
A review of the pharmacokinetics and pharmacodynamics of aztreonam.
Ramsey C, MacGowan AP. Ramsey C, et al. J Antimicrob Chemother. 2016 Oct;71(10):2704-12. doi: 10.1093/jac/dkw231. Epub 2016 Jun 21. J Antimicrob Chemother. 2016. PMID: 27334663 Review.
The monobactam aztreonam is currently being re-examined as a therapeutic agent in light of the global spread of carbapenem resistance in aerobic Gram-negative bacilli and aztreonam's stability to Ambler class B metallo-beta-lactamases. Of particular interest are the …
The monobactam aztreonam is currently being re-examined as a therapeutic agent in light of the global spread of carbapenem resistance …
Aztreonam, a new monobactam antimicrobial.
Guay DR, Koskoletos C. Guay DR, et al. Clin Pharm. 1985 Sep-Oct;4(5):516-26. Clin Pharm. 1985. PMID: 3902330 Review.
In preliminary studies, aztreonam achieved high tissue concentrations and was usually well tolerated. ...Development of resistance during therapy may be less likely with aztreonam than with other new cephalosporins. Aztreonam will probably have an important r …
In preliminary studies, aztreonam achieved high tissue concentrations and was usually well tolerated. ...Development of resistance du …
Aztreonam: a review of the first monobactam.
Westley-Horton E, Koestner JA. Westley-Horton E, et al. Am J Med Sci. 1991 Jul;302(1):46-9. doi: 10.1097/00000441-199107000-00011. Am J Med Sci. 1991. PMID: 2063887 Review.
Aztreonam represents the first synthetic monobactam marketed in the United States and is being viewed as a nontoxic alternative to the aminoglycosides. Advantages of aztreonam over the aminoglycosides include lack of ototoxicity and nephrotoxicity and better penetra …
Aztreonam represents the first synthetic monobactam marketed in the United States and is being viewed as a nontoxic alternative to th …
4,130 results

Searches related to "aztreonam"